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ABSTRACT Endogenous protein phosphorylation was inves-
tigated in cultured rat Sertoli cells after treatment with follicle-
stimulating hormone (FSH) and pharmacological agents that ac-
tivate cAMP-dependent protein kinases. In intact Sertoli cells,
both phosphorylation and dephosphorylation of proteins occurred
in response to treatment with these agents. Studies using cell-free
preparations suggest that four phosphoproteins phosphorylated
by cAMP or the catalytic subunit of cAMP-dependent protein ki-
nase were also phosphorylated in a FSH-dependent manner in
intact cells. These data suggest that FSH-dependent phosphoryla-
tion in Sertoli cells occurs through activation ofa cAMP-dependent
protein kinase. A FSH-dependent phosphoprotein with a molec-
ular weight of 58,000 was identified as the intermediate filament
protein vimentin, based on its migration in two-dimensional gels
and its peptide map. The cellular distribution of vimentin was
monitored by immunofluorescence in Sertoli cells after treatment
with FSH. Results of this study support a role for intermediate
filaments in FSH-dependent events in Sertoli cells.
Sertoli cell function is regulated by both testosterone and fol-
licle-stimulating hormone (FSH) (1, 2). The development of
techniques for the isolation and culture of Sertoli cells (3-5) has
provided an opportunity to study their hormonal regulation. We
have previously reported the cellular distribution of immuno-
reactive androgen-binding protein (6), the temporal sequence
of Sertoli cell shape changes (7), and protein synthesis and se-
cretion (8) in cultured Sertoli cells in response to FSH treat-
ment. Results ofthese studies support a cAMP-mediated mech-
anism that induces alterations in components of the cytoskeleton
that may play a role in the processing ofproteins by Sertoli cells.
To further characterize the regulatory mechanisms involved
in FSH action on Sertoli cells, experiments were conducted to
examine the role ofprotein phosphorylation in modulating FSH
effects. To date, no specific FSH-dependent protein substrates
have been identified.
Our findings show that treatment of Sertoli cells with FSH
or a cyclic nucleotide analog results in both phosphorylation and
dephosphorylation of several polypeptides. One of the proteins
phosphorylated in a FSH-dependent manner was identified as
the intermediate filament protein (IFP) vimentin, a cytoskele-
ton component of Sertoli cells (7).
MATERIALS AND METHODS
Materials. Ovine FSH (NIH-FSH-S12) was provided by the
Pituitary Distribution Program of the National Institute of Ar-
thritis, Metabolism, and Digestive Diseases. 2-Mercaptoetha-
nol, phenylmethylsulfonyl fluoride, N6,02'-dibutyryladeno-
sine 3',5'-phosphate (Bt2cAMP), N-morpholinepropanesul-
fonic acid (Mops), EGTA, ATP, and cAMP were from Sigma.
1-Methyl-3-isobutyl-xanthine (MeiBuXan, "MIX") was from
Aldrich. Fluorescein isothiocyanate-conjugated goat anti-rab-
bit IgG was from Cappel Laboratories (Cochranville, PA).
[y-32P]ATP (2,000-4,000 Ci/mmol; 1 Ci = 37 GBq) and carri-
er-free 32Pi were from New England Nuclear. Ultrapure urea
was from Schwarz/Mann. Gel electrophoresis reagents were
from Bio-Rad and Pharmacia.
Cell Culture and Preparation of Cell Fractions.- Primary
cultures of Sertoli cells were prepared from 20- to 22-day-old
rats as described (9). Sertoli cells were maintained in serum-free
medium for 18-24 hr prior to the addition of various agents.
Attached cells were incubated in a humidified atmosphere at
32TC. Cells were collected in cold 20mM Mops, pH 7.0/10 mM
MgCl2/0.2 mM EGTA/150mM NaCl, dispersed by sonication
for 15 sec (10), and then centrifuged at 27,000 X g for 10 min.
Portions of the supernatant were used to assay protein kinase
activity or endogenous phosphorylation. In some experiments,
Sertoli cells were collected in 20 mM Mops, pH 7.0/150 mM
NaCl/2 mM 2-mercaptoethanol and homogenized in a glass
Dounce homogenizer (small-clearance pestle). After homoge-
nization, MgCl2 was added to a final concentration of 10 mM.
The cell homogenate was centrifuged at 600 X g for 3 min and
supernatants were collected and centrifuged at 100,000 x g for
60 min.
Protein Kinase Assay. Reaction mixtures (150 ,ul) contained
20 mM Mops, pH 7.0, 10 mM MgCl2, 0.2 mM MeiBuXan, 0.2
mM EGTA, histones H1 and H2B. (1.0 mg/ml), 25-50 ,tM
[y-32P]ATP (100-200 cpm/pmol), .and 20-30 ,ug of protein with
or without 2-10 ,uM cAMP. Reactions were run for 10 min at
30°C and activity was assayed by spotting on filter disks as de-
scribed (10).
In Vitro Phosphorylation of Cell-Free Extracts. Sertoli cells
were collected and processed as described above except that
0.1 mM phenylmethylsulfonyl fluoride was included in the ho-
mogenization buffer. Reaction mixtures (150 ,ul) contained 20
mM Mops, pH 7.0, 10mM MgCl2, 0.2mM MeiBuXan, 0.2 mM
EGTA, 1-5 ,uM [y-32P]ATP (4 to 5 ,ACi per tube), 10-20 ,uM
cAMP, and 25-50 ,ug of protein. Reactions were run for 10 min
at 30°C and samples were spotted on filter disks as described
(10). The remaining portion of each mixture was mixed with an
equal volume of double-strength NaDodSO4 sample buffer (11)
and boiled for 5 min.
In Vitro Phosphorylation of Intact Sertoli Cells. Pulse-la-
beling with 32p was carried out as described by Le Cam et al
(12). The agents were added to Sertoli cells in fresh serum-free
medium containing 5-10% of the normal phosphate concentra-
Abbreviations: FSH, follitropin, follicle-stimulating hormone; C sub-
unit, catalytic subunit of cAMP-dependent protein kinase; cAMP/ki-
nase, cAMP-dependent protein kinase; IFP, intermediate filament pro-
tein; Bt2cAMP, N6,02'-dibutyryladenosine 3',5'-phosphate; Me-
iBuXan, 1-methyl-3-isobutylxanthine; Mops, N-morpholinepropane-
sulfonic acid.
993
The publication costs ofthis article were defrayed in part by page charge
payment. This article must therefore be hereby marked "advertise-
ment" in accordance with 18 U. S. C. §1734 solely to indicate this fact.
Proc. Natl. Acad. Sci. USA 80 (1983)
tion and 32p; (250-800 /LCi/ml) was added to the culture dishes
during the last 20 min of incubation with the agents. For one-
dimensional polyacrylamide gel electrophoresis, reactions were
terminated by removal of media and rinsing the Sertoli cells
with phosphate-buffered saline. NaDodSO4 sample buffer was
then added to the dishes and the samples were boiled for 10
min. For two-dimensional gel electrophoresis, the cells were
rinsed with Hanks' balanced salt solution and centrifuged at
1,000 rpm for3 min. The salt solution was removed by aspiration
and 150 p.l of lysis buffer (11) was added to the cells.
Polyacrylamide Gel Electrophoresis and Autoradiography.
One- and two-dimensional NaDodSO4/polyacrylamide gel
electrophoresis, using a 5-15% acrylamide (linear gradient) slab
gel, was carried out as described (11). Gels were processed as
described (10).
Peptide Mapping. One-dimensional peptide mapping after
limited proteolysis was carried out by the procedure of Cleve-
land et al (13) as described (10).
Immunoprecipitation. Sertoli cells were labeled for 16 hr in
low-methionine (10% of normal) medium containing [3S]-
methionine at 100 p.Ci/ml. The cells were collected, centri-
fuged at 1,000 rpm for 3 min, and solubilized by boiling for 5
min with 2% NaDodSO4/5% 2-mercaptoethanol.
The samples were diluted (1:20) with 0.5% Triton X-100 in
phosphate-buffered saline and centrifuged at 100,000 x g for
30 min. Immunoprecipitation was carried out as described by
Murphy et al. (14) except that Staphylococcus aureus protein
A absorbent (15) was substituted for the second antibody.
Indirect Immunofluorescence. Immunocytochemical exper-
iments were conducted as described (6, 7). Coverslips were
mounted with Elvanol (16). Controls for specificity involved
(i) omission of the primary antiserum, (ii) absorption of the anti-
serum with IFP, and (iii) immunoprecipitation of '35S]methionine-
labeled extracts.
RESULTS
cAMP-Dependent Protein Kinase (cAMP/Kinase) Activity
in Sertoli Cells. Because activation of cAMP/kinase provides
an important regulatory mechanism for many cellular processes
through protein phosphorylation (17), we examined the effects
of FSH and pharmacological agents that elevate intracellular
cAMP in cultured Sertoli cells. Incubation of Sertoli cells with
FSH or the phosphodiesterase inhibitor MeiBuXan for 30 min
resulted in moderate activation of soluble cAMP/kinase. How-
ever, treatment of Sertoli cells with FSH/MeiBuXan or with
Bt2cAMP for 30 min significantly stimulated cAMP/kinase ac-
tivity (Fig. 1). These findings agree with a previous report (18).
Activation of cAMP/kinase occurs within 5 min after exposure
of Sertoli cells to FSH in the presence of MeiBuXan (19) and
is maintained up to 1 hr after treatment (activity ratios: 0.89 vs.
0.67).
Endogenous Protein Phosphorylation in Cell-Free Extracts.
We next investigated in vitro protein phosphorylation following
treatment with agents that activated cAMP/kinase on the as-
sumption that cAMP/kinase activation in intact Sertoli cells in
response to hormone could be maintained and examined in vitro
by incubation in the presence of [y-32P]ATP. When protein
phosphorylation patterns in soluble fractions (27,000 x g) were
examined under these conditions (Fig. 2), previous treatment
with Bt2cAMP or FSH/MeiBuXan enhanced phosphorylation
of at least nine proteins (Mr, >330,000, 140,000, 98,000,
85,000, 73,000, 58,000, 39,000, 27,000, and 24,000). However,
treatment with FSH or MeiBuXan alone only moderately al-
tered the protein 32P-labeling patterns when compared with
control samples.
When a whole cell sonicate was incubated with cAMP or the











































































































FIG. 1. cAMP/kinase activity in Sertoli cells aftertreatment with
FSH (10 pg/ml), MeiBuXan (MIX; 0.4 mM), FSH/MeiBuXan, or
Bt2cAMP (0.5 mM) for 30 min. Activity ratios (in parentheses) reflect
protein kinase activities measured in the absence (E) or presence
(H) of 10 uM cAMP. Results represent mean ± SEM of five deter-
minations.
tion of at least six proteins (Mr, >330,000, 140,000, 85,000,
39,000, 27,000, and 24,000) increased (Fig. 3). In addition,
three other proteins (Mr, 58,000, 45,000, and 41,000) were
phosphorylated in the presence of the C subunit but not in the
presence of cAMP.
Endogenous Protein Phosphorylation in Intact Sertoli Cells.
While several proteins present in cell-free extracts were phos-
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FIG. 2. Effect of previous treatment with various agents on protein
phosphorylation of cell-free extracts in vitro. Sertoli cells were incu-
bated for 30 min with 0.5mM Bt2cAMP (lanes 3 and 4), FSH at 20 ,ug/
ml (lanes 7 and 8), 0.1 mM MeiBuXan (lanes 9 and 10), or FSH/
MeiBuXan (lanes 5 and 6) and the 27,000 x g soluble fraction prepared
from cell sonicates (lanes 1 and 2: control cells) in the presence (lanes
2, 4, 6, 8, and 10) or absence (lanes 1, 3, 5, 7, and 9) of 20 p.M cAMP.
The following amounts of protein were loaded on the gels: lanes 1 and
2, 32 ,ug; lanes 3 and 4, 33 ,ug; lanes 5 and 6, 40 jug; lanes 7 and 8, 36
pug; lanes 9 and 10, 34 gg. Numbers on the left and right represent M,
X 10-3.
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36 - 39 FIG. 3. Endogenous protein phospho-
30 - rylation in cell-free extracts of Sertoli
27 cells: Autoradiogram showing the protein
20 - 24 phosphorylation patterns in cell sonicates
incubated with exogenous 20 juM cAMP
14 - (lane 2) or 2 ug of C subunit (lane 3). Lane
1: control cells. Numbers are as in Fig. 2.
phorylated in vitro by cAMP or the C subunit or after treatment
with FSH or Bt2cAMP, we examined endogenous protein phos-
phorylation in intact Sertoli cells because the loss of compart-
mentation in cell-free extracts could allow access to nonphysi-
ological substrates (20). The protein phosphorylation pattern in
intact Sertoli cells pulse-labeled with 32Pi during a 2-hr incu-
bation period with various agents is shown in Fig. 4. Both phos-
phorylation and dephosphorylation of specific proteins were
apparent as early as 20 min after treatment and persisted after
3 hr of exposure to the agents (data not shown). Three proteins
(Mr, 140,000, 73,000, and 85,000) showed enhanced phosphor-
ylation after treatment with all the agents tested, whereas a Mr
58,000 protein showed moderate enhancement in 32p labeling
only after exposure to Bt2cAMP and FSH/MeiBuXan (Fig. 4).
While changes in 32p labeling were not quantitated, there ap-
peared to be differences in labeling intensities depending on
the treatment. Interestingly, two proteins (Mr, 20,000 and
19,000) showed a striking decrease in 32p labeling after treat-
ment with FSH/MeiBuXan, MeiBuXan, or Bt2cAMP but not
with FSH alone.
cAMP-Dependent Phosphorylation of Vimentin. In a pre-
vious study (10), we showed that the IFP vimentin was phos-
phorylated in a Ca2+/calmodulin-dependent manner in cell-
free preparations of Sertoli cells. Vimentin has been shown to
be phosphorylated in a cAMP-dependent manner in other cell
types (21, 22). It became apparent during the course of this
study that the Mr 58,000 protein phosphorylated by the C sub-
unit (Fig. 3) and by previous treatment ofintact Sertoli cells with
FSH or Bt2cAMP (Fig. 2) was probably vimentin. When a Tri-
ton X-100-insoluble IFP extract was prepared from Sertoli cells
as described (10) and incubated with the C subunit, a Mr 58,000
protein in the preparation was phosphorylated. Peptide maps
of this phosphoprotein (Fig. 5) were identical to those reported
for phosphorylated vimentin (10, 23).
Hormone-Dependent Phosphorylation of Vimentin. Since
vimentin was phosphorylated in a cAMP-dependent manner in
cell-free extracts and a Mr 58,000 protein was phosphorylated
in intact Sertoli cells after treatment with FSH or Bt2cAMP
(Fig. 4), we used two-dimensional polyacrylamide gel electro-
phoresis to determine whether the hormone-dependent phos-
phoprotein was vimentin. Numerous changes in 32P-labeling
intensity were noted after 1 hr treatment with FSH (Fig. 6C)
or Bt2cAMP (Fig. 6D) when compared with control Sertoli cells
(Fig. 6B). In general, changes in phosphorylation observed in














FIG. 4. Endogenous protein phosphorylation in intact Sertoli cells.
Cells were incubated with FSH at 10 pg/ml (lanes 2), 0.25 mM
MeiBuXan (lanes 3), FSH/MeiBuXan (lanes 4), or 0.5 mM Bt2cAMP
(lanes 5) for 120 min and pulse-labeled with 32p; for 20 min. Lanes 1:
control cells. (A) Coomassie blue staining pattern. (B) Autoradiogram
of the stained gel. Phosphorylation/dephosphorylation changes are
noted by arrowheads. Numbers on the right of the gels are as in Fig.
2.
When the autoradiograms were brought into register with
Coomassie blue-stained gels, one polypeptide spot on the au-
toradiogram (Mr, 58,000; pI, 5.1) (designated V in Fig. 6) ap-
peared shifted to the acidic side of the corresponding stained
spot. This phosphorylation pattern has been reported for vi-
mentin phosphorylation in other cell types (24, 25). This par-
ticular behavior of the protein, in addition to its Mr and pI, sup-
port its identity as vimentin.
Immunocytochemical Localization of Vimentin in Sertoli
Cells. Using an antiserum that crossreacts with vimentin-type







* < FIG. 5. One-dimensional pep-
tide map of phosphorylated vimen-
tin. An IFP extract prepared from
Sertoli cells was added to a soluble
20- fraction (27,000 x g) of a Sertoli
cell sonicate and incubated in the
- presence (lane 2) and absence (lane
* .< 1) of 0.7 tg of C subunit. Digestion
was carried out with 0.02 ug of S.
14 - O aureus V8 protease. Proteolyticfragments are indicated by arrow-
heads. Numbers on the left are as
in Fig. 2.
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vimentin in cultured Sertoli cells after exposure to FSH or
Bt2cAMP by indirect immunofluorescence. Immunoprecipi-
tation of [LS]methionine-labeled extracts of Sertoli cells con-
firmed crossreactivity of the antiserum with Sertoli cell vimen-
tin (Fig. 7). Immunoreactive vimentin was localized in the
cytoplasm of control Sertoli cells as a diffuse filamentous net-
work (Fig. 8 A and B). The fluorescence was abolished by ab-
sorption of the antiserum with IFP prepared from Sertoli cells
(data not shown); Sertoli cells treated with FSH for 60 min dis-
played the characteristic flat-stellate transition (Fig. 8C). Vi-
mentin immunoreactivity in morphologically responsive Sertoli
cells appeared restricted to the long cytoplasmic processes and
the perinuclear region. Treatment with Bt2cAMP (Fig. 8D) re-
sulted in similar fluorescence patterns except that the morpho-
logical response was more rapid and extensive in agreement









FIG. 7. Immunoprecipitation of
[35S]methionine-labeled extracts
with vimentin antiserum. Minor
labeled bands represent nonspe-
cific adsorption since the back-
ground was not reduced by further
dilution of antiserum. The autora-
diogram was obtained after a 10-
day exposure. Numbers are as in
Fig. 2.
D. FIG. 6. Two-dimensional polyacryla-
mide gel electrophoresis analysis of pro-
tein phosphorylation patterns in intact
Sertoli cells. Cells were incubated with
FSH at 10 pg/ml (C) or with 0.5 mM
Bt2cAMP (D) for 60 min, pulse-labeled
with 32P, for 20 min and autoradio-
graphed. (A andB) Coomassie blue stain-
ing pattern of control Sertoli cells and the
corresponding autoradiogram of the 32p
labeling pattern, respectively. Autoradi-
ograms were obtained after a 14-day ex-
posure. V, vimentin. Numbers on the left
are as in Fig. 2.
of Franke et aL (27) that intermediate filaments in Sertoli cells
are of the vimentin type.
DISCUSSION
We have examined cAMP/kinase activity and the phosphoryla-
tion of intracellular proteins in cultured rat Sertoli cells as an
approach to the understanding of FSH regulation of Sertoli cell
function. cAMP/kinase activation in response to FSH precedes
the development of morphological changes (7), supporting a
possible relationship between the phosphorylation of intracel-
lular proteins and alteration in the cytoskeleton. When protein
phosphorylation patterns were examined in vitro after exposure
of Sertoli cells to various agents, previous treatment with FSH/
MeiBuXan or Bt2cAMP- significantly enhanced protein phos-
FIG. 8. Immunocytochemical localization of vimentin in cultured
Sertoli cells. (A andB) Distribution of vimentin in control Sertoli cells.
(A, x 160; B, x480.) (C) Distribution after 60 min of treatment with
FSH at 10 pg/ml. (x130.) (D) Distribution after 60 min of treatment
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phorylation whereas previous treatment of Sertoli cells with
FSH or MeiBuXan alone resulted in moderate phosphorylation
changes. This agent-dependent effect on protein phosphoryl-
ation correlated well with a similar agent-dependent activation
of cAMP/kinase (Fig. 1). The differences in cAMP/kinase ac-
tivity and protein phosphorylation observed between treatment
with FSH or MeiBuXan alone versus FSH/MeiBuXan or
Bt2cAMP treatment may be related to high concentrations of
a cAMP/kinase inhibitor present in Sertoli cells of 20- to 22-
day-old rats (28). High levels ofcAMP may be required to over-
come cAMP/kinase inhibition, a requirement that is even more
important in cell-free extracts because of the loss of cell com-
partmentation.
Based on similarities in Mr results from experiments using
intact Sertoli cells suggest that the four major FSH-dependent
phosphoproteins were the same proteins phosphorylated in a
cAMP-dependent manner in cell-free extracts. These obser-
vations support FSH-dependent protein phosphorylation in
Sertoli cells as being mediated by cAMP/kinase activation. Of
the four major hormone-dependent phosphoproteins, our in-
terest focused on one, the Mr 58,000 phosphoprotein. This pro-
tein was phosphorylated in a FSH-dependent manner in both
cell-free extracts and intact cells. Based on the following cri-
teria, this protein was identified as the IFP vimentin: (i) its Mr
of 58,000 and pI of 5.1, (ii) the similarity of the peptide maps
of the Mr 58,000 phosphoprotein and ofphosphorylated vimen-
tin, (iii) the shift of the Mr 58,000 phosphoprotein to the acidic
side of Coomassie blue-stained protein on two-dimensional
gels, and (iv) immunoprecipitation of a Mr 58,000 protein from
[35S]methionine-labeled extracts with a vimentin antiserum.
Both cAMP and Ca2' are thought to play important roles as
intracellular regulators of Sertoli cell function (2, 29). The re-
sults of the present study suggest that phosphorylation of vi-
mentin in Sertoli cells, triggered by FSH, occurs in a cAMP-
dependent manner. However, since vimentin in Sertoli cells
can also be phosphorylated in a Ca2+/calmodulin-dependent
manner under certain conditions (10), a role for Ca2+/cal-
modulin in FSH-dependent processes cannot be ruled out.
While the C subunit and calmodulin (10) appear to phosphor-
ylate residues on the same proteolytic fragments, further anal-
ysis is required to determine whether the same residues are
phosphorylated.
One intriguing question is the possible role ofvimentin phos-
phorylation in Sertoli cells. In C-6 glioma cells, vimentin phos-
phorylation occurs after treatment with norepinephrine (30). In
response to norepinephrine, glioma cells display a transient
alteration in cell shape (31) and synthesize and release nerve
growth factor (32). In Sertoli cells, FSH induces transient
changes in cell morphology (7) and promotes the synthesis and
release ofseveral proteins (8, 33, 34). Because vimentin is phos-
phorylated in both glioma cells and Sertoli cells in response to
hormones that induce cell shape changes, it is attractive to sug-
gest a role for intermediate filaments in the hormonal induction
ofan altered cell morphology. Our immunocytochemical studies
show that vimentin-type intermediate filaments in cultured
Sertoli cells are not disrupted as Sertoli cells modify their shape
from a flat to a stellate morphology in response to FSH. If FSH-
induced phosphorylation of vimentin in cultured Sertoli cells
can be related to the induction of cell shape changes, it is pos-
sible that a similar hormone-mediated mechanism acts on the
elaborate cytoskeletal network in Sertoli cells in vivo. A dynamic
modification of cytoskeletal components in Sertoli cells in the
seminiferous epithelium may be required for a variety of pro-
cesses related to spermatogenic events (7, 9).
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